|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 04797879.6 (espacenet) (Federated) (European Patent Register), 20041113 | Patent/reg. no. and date | DK/EP 1689370, 20080213 | Publication date | 20060816 | Priority no. and date | DE 10355461, 20031127 | EP pub. no. and date |
EP 1689370 20060816 | Effective date | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel Strasse 50
40789 Monheim am Rhein, DE | Applicant ref. no. | SH/GP/131815 | Inventor | BENKE, Klaus, Malteserweg 16
51465 Bergisch Gladbach, DE | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/5377 (2006.01) , A61K 9/20 (2006.01) , A61P 7/02 (2006.01) | Title | Fremgangsmåde til fremstilling af en fast, oralt indgivelig farmaceutisk sammensætning med 5-chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid | Int. application no. | EP2004012897 | Int. publication no. | WO2005060940 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |